Day: May 1, 2020
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWCALGARY, Alberta, April 30, 2020 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) (“High Arctic”, the “Corporation” or “We”) is pleased to report on outstanding operational safety performance and progress made on previously announced cost reduction measures. On April 16, 2020 the Corporation’s Production Services operation with our major customer at Cold Lake, Alberta reached the world-class milestone of seven (7) years Total Recordable Incident Free. It is our largest single operation with many of the Corporation’s well servicing rigs on contract with a top-tier major customer. Over the seven years, the team amassed 1.64 million...
Goldquest: Grant of Stock Options
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, April 30, 2020 (GLOBE NEWSWIRE) — GoldQuest Mining Corp. (TSXV:GQC, “GoldQuest” or the “Company”) announces that the board of directors of the Company has authorized the grant of an aggregate of 3,400,000 incentive stock options (the “Options”) to directors, officers and employees of the Company, at an exercise price of $0.20 per common share.The Options are exercisable for a five-year period from the date of grant and will vest as follows: ⅓ on the date of grant, ⅓ on the six month anniversary from the date of the grant and ⅓ on the one year anniversary from the date of the grant.The Options are granted pursuant to the Company’s stock option plan, which was most recently approved by shareholders at the Company’s annual general meeting of shareholders held on June 28, 2019.About GoldQuestGoldQuest is...
Annual General Meeting Voting Results
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, April 30, 2020 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE:PVG) (“Pretivm” or the “Company”) announces the voting results from its Annual General Meeting of shareholders held today (the “Meeting”). A total of 132,934,862 (71.65%) of Pretivm’s common shares were represented at the Meeting.The seven nominees listed in the management information circular with respect to the Meeting were elected as directors of Pretivm. Detailed results of the vote for the election of directors are set out below:Number of DirectorsSetting the number of Directors at seven:Election of DirectorsFollowing the Meeting, Pretivm’s Board of Directors appointed Jacques Perron, the Company’s President and Chief Executive Officer, as a director of the Company.Voting results with respect to the other matters at the Meeting,...
Installux : Rapport Financier Annuel 2019
Written by Customer Service on . Posted in Public Companies.
Avis de mise à disposition du rapport financier annuel 2019Le rapport financier annuel 2019 du Groupe Installux est consultable à l’adressesuivante :http://www.worldreginfo.com/rd/idefault.asp?uid=%7b5A3E8E6C-26B0-4842-BE01-95E8548428A5%7dPièce jointeAvis de mise à disposition du rapport financier annuel 2019
Telix Pharmaceuticals submits European marketing authorisation application for prostate cancer imaging product
Written by Customer Service on . Posted in Public Companies.
MELBOURNE, Australia and LIÈGE, Belgium, May 01, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has submitted a marketing authorisation application (MAA) in Europe for TLX591-CDx (68Ga-PSMA-11 Injection) for the imaging of prostate cancer with Positron Emission Tomography (PET).The submission has been made to the Danish Medicines Agency (DKMA) in its capacity as a reference Competent Authority of a European member state. The DKMA will coordinate and lead the evaluation of Telix’s MAA for TLX591-CDx on behalf of Denmark as well as a selection of European countries, nominated by Telix. These countries reflect the major European markets for Telix’s prostate cancer imaging product.In accordance with the current European Association of Urology (EAU) guidelines on prostate...
TIM PARTICIPAÇÕES S.A.: Filing of annual report on Form 20-F for the year ended in December 31, 2019
Written by Customer Service on . Posted in Public Companies.
RIO DE JANEIRO, Brazil, April 30, 2020 (GLOBE NEWSWIRE) — TIM Participações S.A. (“Company”) (B3:TIMP3) (NYSE:TSU) hereby informs its shareholders and the market in general that it has filed its 2019 annual report (“Form 20-F”) for the calendar year ended December 31, 2019 with the U.S. Securities and Exchange Commission (“SEC”).The Form 20-F is available for download on the Company’s Investor Relations website, www.tim.com.br/ir, and, in addition, shareholders may receive a hard copy of the Form 20-F and the complete financial statements, free of charge, by requesting in the following channels: by telephone (+55 21) 4109-4167 or by email ri@timbrasil.com.br.Any further information regarding the Form 20-F can be obtained by contacting Investor Relations Team and/or Mr. Adrian Calaza, Chief Financial Officer and...